908 Devices (MASS) Current Deferred Revenue (2020 - 2026)
908 Devices' (MASS) quarterly Current Deferred Revenue came in at $9.5 million in Q1 2026, down 50.79% year-on-year from $19.2 million in Q1 2025, and up 6.0% on a QoQ basis from $8.9 million in Q4 2025.
908 Devices (MASS) Current Deferred Revenue (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Current Deferred Revenue data on file, last reported at $9.5 million in Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 50.79% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $9.5 million, a 50.79% decrease from a year earlier, with the FY2025 full-year figure at $8.9 million, down 56.69% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $9.5 million, up from $8.9 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for MASS reached as high as $22.5 million in Q3 2024 and fell as low as $8.8 million in Q2 2025.
- Historically, Current Deferred Revenue has averaged $15.9 million across 5 years, with a median of $16.5 million in 2022.
- Across the five-year window, Current Deferred Revenue soared 63.63% in 2022 and tumbled 59.5% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $16.5 million in 2022, then increased by 3.6% to $17.1 million in 2023, then gained by 20.62% to $20.6 million in 2024, then plunged by 56.69% to $8.9 million in 2025, then climbed by 6.0% to $9.5 million in 2026.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $9.5 million in Q1 2026, $8.9 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | 908 Devices | 261.96 Mn | 150.22 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.47 Mn |
| Dec 31, 2025 | 8.93 Mn |
| Sep 30, 2025 | 9.11 Mn |
| Jun 30, 2025 | 8.83 Mn |
| Mar 31, 2025 | 19.24 Mn |
| Dec 31, 2024 | 20.63 Mn |
| Sep 30, 2024 | 22.48 Mn |
| Jun 30, 2024 | 19.04 Mn |
| Mar 31, 2024 | 15.90 Mn |
| Dec 31, 2023 | 17.10 Mn |
| Sep 30, 2023 | 19.89 Mn |
| Jun 30, 2023 | 19.29 Mn |
| Mar 31, 2023 | 16.39 Mn |
| Dec 31, 2022 | 16.51 Mn |
| Sep 30, 2022 | 16.89 Mn |
| Jun 30, 2022 | 15.89 Mn |
| Mar 31, 2022 | 14.84 Mn |
| Dec 31, 2021 | 14.52 Mn |
| Sep 30, 2021 | 12.75 Mn |
| Jun 30, 2021 | 9.71 Mn |